Merck & Co., known as MSD outside the United States and Canada, has entered into a multi-year agreement with the Vector Institute in Toronto, an independent not-for-profit corporation dedicated to advancing the field of artificial intelligence (AI) through research, allowing Merck Canada to gain access to Vector’s research capabilities and expertise in AI and engage with its ecosystem to drive innovation in healthcare.   As such, Merck Canada will have the opportunity to tap into Vec...